Skip to main content
. 2022 Mar 17;2022:1120192. doi: 10.1155/2022/1120192

Table 1.

Comparison of clinical characteristics between favorable and poor outcome.

Variables Favorable outcome Poor outcome p value
( n = 169) ( n = 65)
Demographic characteristics
 Age (years) 66 (55.5-75) 75 (67-82.5) <0.001
 Sex (male, n %) 112 (66.3) 38 (58.5) 0.265
Vascular risk factors, (n %)
 Hypertension (n %) 107 (63.3) 51 (78.5) 0.027
 Diabetes (n %) 73 (43.2) 30 (46.2) 0.683
 Hyperlipidemia (n %) 52 (30.8) 22 (33.8) 0.650
 History of stroke (n %) 15 (8.9) 14 (21.5) 0.008
 Atrial fibrillation (n %) 42 (24.9) 34 (52.3) <0.001
Clinical data
 Baseline NIHSS 6.00 (4.00-9.00) 13.00 (8.00-18.00) <0.001
Laboratory indexes
 WBC (×109/L) 7.08 ± 1.85 8.66 ± 2.58 <0.001
 RBC (×1012/L) 4.41 ± 0.49 4.28 ± 0.53 0.078
 Platelet (×109/L) 197.35 ± 54.89 197.88 ± 57.35 0.948
 Albumin (g/L) 38.18 ± 2.92 38.06 ± 3.21 0.788
 Globulin (g/L) 26.70 ± 3.90 28.95 ± 4.94 <0.001
 Prealbumin (g/L) 0.23 (0.20-0.27) 0.22 (0.18-0.25) 0.005
 UA (μmol/L) 331.48 ± 81.44 317.78 ± 98.03 0.278
 BUN (mmol/L) 4.60 (3.95-5.67) 5.28 (4.03-6.22) 0.060
 TC (mmol/L) 4.53 (4.01-5.24) 4.67 (3.69-5.61) 0.601
 HDL-C (mmol/L) 1.07 (0.94-1.28) 1.03 (0.89-1.34) 0.660
 LDL-C (mmol/L) 2.90 ± 0.90 3.07 ± 1.07 0.219
 Apo-A1 (g/L) 1.29 (1.17-1.43) 1.23 (1.10-1.49) 0.357
 Apo-B1 (g/L) 0.92 (0.78-1.06) 0.93 (0.81-1.12) 0.453
 GPR 111.92 (93.74-135.75) 136.32 (106.05-174.08) <0.001
 GAR 0.70 ± 0.11 0.77 ± 0.13 0.001

Abbreviations: NIHSS: National Institute of Health Stroke Scale; WBC: white blood cell count; UA: uric acid; RBC: red blood cells; BUN: blood urea nitrogen; TC: triglyceride; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; Apo-A1: apolipoprotein-A1; Apo-B1: apolipoprotein-B1; GPR: globulin to prealbumin ratio; GAR: globulin to albumin ratio.